Market Introduction & Size Analysis:
The global monoclonal antibodies market is projected to reach approximately US$729.4 billion by the end of 2031, up from US$276.9 billion in 2024, representing a robust CAGR of 12.4% from 2024 to 2031. This growth underscores the increasing importance of monoclonal antibodies within the biopharmaceutical sector.
The Monoclonal antibodies (mAbs) market...
0 Commentarios
0 Acciones
501 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian